{"id":56297,"date":"2023-04-27T16:04:24","date_gmt":"2023-04-27T14:04:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/"},"modified":"2023-04-27T16:04:24","modified_gmt":"2023-04-27T14:04:24","slug":"hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/","title":{"rendered":"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit"},"content":{"rendered":"
\n

LA JOLLA, Calif.–(BUSINESS WIRE)–Hearing at Home LLC<\/a>, a leading direct-to-consumer provider of cost-effective, reliable hearing aids, announces the appointment of Kevin J. Flick<\/a> <\/b>as Chief Financial Officer effective May 1.<\/p>\n

<\/a><\/p>\n

\nFlick is a seasoned financial executive with experience at Goldman Sachs, Hicks, Muse, Tate & First, Ernst & Young, as well as Transatlantic and Canacol in the energy sector.<\/p>\n

\n\u201cKevin has distinguished himself through his integrity, his strategic acumen, and his unwavering focus on profitable growth wherever he has been,\u201d declared Hearing at Home CEO David G. Burke<\/a>.<\/p>\n

\n\u201cKevin\u2019s primary areas of focus will be on accelerating our pursuit of additional EBITDA growth, driving improved operating metrics for brand Nano, profitably launching our new brands, and helping us find the talent to lead and grow our company to achieve our shared purpose.<\/p>\n

\n\u201cI want to say a special thanks to current CFO Chris Meinerz<\/a> for all his many contributions to Nano Technologies,\u201d said Burke. \u201cChris served before the core of the current team was in place, and solved many of the early business challenges that came with the acquisition. Those of us here now owe him a debt of gratitude, and I will miss his enthusiastic presence. We all wish Chris the very best in his future endeavors.\u201d<\/p>\n

\nAccording to the Hearing Loss Association of America<\/a>, some 48 million Americans have some form of hearing loss. Only 3 out of 10 consumers have received effective treatment for a variety of reasons. Fortune Business Insights<\/a> predicts the U.S. hearing aids market size is projected to grow from $3.46 billion in 2022 to $5.86 billion by 2029 driven by powerful secular trends.<\/p>\n

\n\u201cToday\u2019s consumer experience is full of stress and pressure,\u201d commented Burke. \u201cFrom doctor visits to clinical attendance for tests to long waits, and finally to hearing aids costing as much as $8,000 that might not work as promised.<\/p>\n

\n\u201cHearing at Home intends to permanently extinguish the cognitive overload, leading to better outcomes for a growing community that remains demonstrably underserved by legacy equipment manufacturers protecting a decades-old business model. It is long past time to put consumer needs first,\u201d said Burke. \u201cTo grow to realize that objective, Hearing at Home will build advantaged brands, embrace emerging technologies, and existentially seek strategic partners.\u201d<\/p>\n

\nABOUT HEARING AT HOME<\/b><\/p>\n

\nHearing at Home LLC<\/a> is a multi-branded, direct-to-consumer leader in hearing devices. Our vision is to disrupt and reshape the legacy hearing aid market through a disciplined focus on the consumer value proposition by eliminating the pain points. Our brands will be top of mind for the tens of millions of consumers of all ages who are underserved by the hearing aid industry of today.<\/p>\n

Contacts<\/b> <\/p>\n

\nAndrew Bowen
\n
404-822-3309
\n
ab@clearviewcom.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LA JOLLA, Calif.–(BUSINESS WIRE)–Hearing at Home LLC, a leading direct-to-consumer provider of cost-effective, reliable hearing aids, announces the appointment of Kevin J. Flick as Chief Financial Officer effective May 1. Flick is a seasoned financial executive with experience at Goldman Sachs, Hicks, Muse, Tate & First, Ernst & Young, as well as Transatlantic and Canacol … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56297","6":"format-standard","7":"category-industry"},"yoast_head":"\nHearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA, Calif.–(BUSINESS WIRE)–Hearing at Home LLC, a leading direct-to-consumer provider of cost-effective, reliable hearing aids, announces the appointment of Kevin J. Flick as Chief Financial Officer effective May 1. Flick is a seasoned financial executive with experience at Goldman Sachs, Hicks, Muse, Tate & First, Ernst & Young, as well as Transatlantic and Canacol ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T14:04:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230427005190\/en\/1776017\/21\/Nano_logo_with_TM_2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit\",\"datePublished\":\"2023-04-27T14:04:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/\"},\"wordCount\":461,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005190\\\/en\\\/1776017\\\/21\\\/Nano_logo_with_TM_2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/\",\"name\":\"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005190\\\/en\\\/1776017\\\/21\\\/Nano_logo_with_TM_2.jpg\",\"datePublished\":\"2023-04-27T14:04:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005190\\\/en\\\/1776017\\\/21\\\/Nano_logo_with_TM_2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005190\\\/en\\\/1776017\\\/21\\\/Nano_logo_with_TM_2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/","og_locale":"en_US","og_type":"article","og_title":"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit - Pharma Trend","og_description":"LA JOLLA, Calif.–(BUSINESS WIRE)–Hearing at Home LLC, a leading direct-to-consumer provider of cost-effective, reliable hearing aids, announces the appointment of Kevin J. Flick as Chief Financial Officer effective May 1. Flick is a seasoned financial executive with experience at Goldman Sachs, Hicks, Muse, Tate & First, Ernst & Young, as well as Transatlantic and Canacol ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-27T14:04:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230427005190\/en\/1776017\/21\/Nano_logo_with_TM_2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit","datePublished":"2023-04-27T14:04:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/"},"wordCount":461,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230427005190\/en\/1776017\/21\/Nano_logo_with_TM_2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/","url":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/","name":"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230427005190\/en\/1776017\/21\/Nano_logo_with_TM_2.jpg","datePublished":"2023-04-27T14:04:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230427005190\/en\/1776017\/21\/Nano_logo_with_TM_2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230427005190\/en\/1776017\/21\/Nano_logo_with_TM_2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hearing-at-home-llc-appoints-kevin-flick-cfo-seasoned-financial-exec-to-fast-track-additional-profit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hearing at Home LLC Appoints Kevin Flick CFO; Seasoned Financial Exec to Fast-Track Additional Profit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56297"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56297\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}